1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Precision Medicine Market
2.2. Global Precision Medicine Market, By Technology Type, 2023 (US$ Million)
2.3. Global Precision Medicine Market, By Applications, 2023 (US$ Million)
2.4. Global Precision Medicine Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Precision Medicine Market: Competitive Analysis
3.1. Market Positioning of Key Precision Medicine Market Vendors
3.2. Strategies Adopted by Precision Medicine Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Precision Medicine Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Precision Medicine Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Companion Diagnostics
5.3.2. Gene Sequencing
5.3.3. Drug Discovery
5.3.4. Big Data Analytics
5.3.5. Bio Informatics
5.3.6. 3D Printing

6. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Oncology
6.3.2. Cardiovascular Diseases
6.3.3. Central Nervous System
6.3.4. Infectious Diseases
6.3.5. Other Diseases


7. North America Precision Medicine Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
7.3. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
7.4.Precision Medicine Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
7.4.1.1.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
7.4.1.2.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
7.4.1.3.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)

8. UK and European Union Precision Medicine Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
8.3. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
8.4.Precision Medicine Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.1.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.2.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.3.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.4.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.5.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
8.4.1.6.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)

9. Asia Pacific Precision Medicine Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
9.3. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
9.4.Precision Medicine Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.1.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.2.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.3.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.4.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.5.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
9.4.1.6.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)

10. Latin America Precision Medicine Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
10.3. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
10.4.Precision Medicine Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
10.4.1.1.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
10.4.1.2.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
10.4.1.3.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)

11. Middle East and Africa Precision Medicine Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
11.3. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
11.4.Precision Medicine Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
11.4.1.1.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
11.4.1.2.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Precision Medicine Market: By Technology Type, 2022-2032, USD (Million)
11.4.1.3.2. Precision Medicine Market: By Applications, 2022-2032, USD (Million)

12. Company Profile
12.1. Biocrates Life Sciences 51
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Nanostring Technologies 52
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Tepnel Pharma Services 53
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Intomics, Ferrer InCode 54
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Abbott Laboratories 55
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Almac Group, Ltd. 57
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. bioMérieux SA 58
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Covance 59
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Menarini Group 60
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Pfizer 61
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Eagle Genomics, Source Precision Medicine, Inc. 63
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Laboratory Corporation of America Holdings 64
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Medtronics 65
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Novartis 66
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. Qiagen 67
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives
12.16. Quest Diagnostics 67
12.16.1. Company Overview
12.16.2. Financial Performance
12.16.3. Product Portfolio
12.16.4. Strategic Initiatives
12.17. Roche Holding 67
12.17.1. Company Overview
12.17.2. Financial Performance
12.17.3. Product Portfolio
12.17.4. Strategic Initiatives
12.18. Teva Pharmaceuticals 68
12.18.1. Company Overview
12.18.2. Financial Performance
12.18.3. Product Portfolio
12.18.4. Strategic Initiatives